含氯法齐明联合方案运用于耐多药结核治疗中的效果观察

发布时间：2018-05-27 00:19

本文选题：含氯法齐明 + 结核病　；参考：《世界最新医学信息文摘》2016年89期

【摘要】：目的研究含氯法齐明联合方案运用于耐多药结核治疗中的效果。方法选取2013年5月至2016年5月期间我院收治结核病患者70例作为研究对象,依据治疗方法不同分为常规组与治疗组,各35例。常规组患者给予常规的抗结核治疗,治疗组在常规组基础上加含氯法齐明治疗,对比两组患者的临床疗效。结果治疗组吸收总有效率为100%,常规组吸收总有效率为82.85%,常规组治疗总有效率显著低于治疗组;治疗组的痰菌转阴率和病灶吸收率都明显优于常规组,两组患者对比存在差异,差异具有统计学意义(P0.05)。结论将保含氯法齐明联合方案治疗结核病患者,临床效果确切,患者病灶吸收率提升,具有较高的应用价值。
[Abstract]:Objective to study the efficacy of chlorfazimine combined regimen in the treatment of multi-drug resistant tuberculosis (MDR). Methods from May 2013 to May 2016, 70 patients with tuberculosis in our hospital were selected as study objects. According to different treatment methods, they were divided into routine group and treatment group, 35 cases in each group. The patients in the routine group were treated with routine antituberculous therapy, and the patients in the treatment group were treated with chlorfazimine on the basis of the routine group, and the clinical effects of the two groups were compared. Results the total effective rate of absorption was 100 in the treatment group and 82.85 in the routine group, and the total effective rate in the routine group was significantly lower than that in the treatment group, the sputum negative conversion rate and the lesion absorption rate in the treatment group were significantly better than those in the conventional group, and there were differences between the two groups. The difference was statistically significant (P 0.05). Conclusion the clinical effect of the combined regimen of perchlorfenazepam in the treatment of tuberculosis patients is accurate, and the lesion absorption rate of the patients is increased, which is of great value in application.
【作者单位】：呼和浩特结核病防治所内科;
【分类号】：R52

【相似文献】